Equities

Aspen Aerogels Inc

Aspen Aerogels Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)13.81
  • Today's Change-0.19 / -1.36%
  • Shares traded988.45k
  • 1 Year change+28.94%
  • Beta2.1378
Data delayed at least 15 minutes, as of Nov 22 2024 19:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform10
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Aspen Aerogels Inc have a median target of 30.00, with a high estimate of 35.00 and a low estimate of 25.00. The median estimate represents a 114.29% increase from the last price of 14.00.
High150.0%35.00
Med114.3%30.00
Low78.6%25.00

Earnings history & estimates in USD

On Nov 06, 2024, Aspen Aerogels Inc reported 3rd quarter 2024 losses of -0.17 per share.
The next earnings announcement is expected on Feb 10, 2025.
Average growth rate-2.63%
Aspen Aerogels Inc reported annual 2023 losses of -0.66 per share on Feb 12, 2024.
Average growth rate-21.98%
More ▼

Revenue history & estimates in USD

Aspen Aerogels, Inc. had 3rd quarter 2024 revenues of 117.34m. This bettered the 109.36m consensus of the 11 analysts covering the company. This was 157.40% above the prior year's 3rd quarter results.
Average growth rate+18.77%
Aspen Aerogels, Inc. had revenues for the full year 2023 of 238.72m. This was 32.35% above the prior year's results.
Average growth rate+18.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.